EXCHANGE TRADED CONCEPTS, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXCHANGE TRADED CONCEPTS, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$1,220,950
+5.8%
42,189
+0.8%
0.03%0.0%
Q3 2023$1,153,915
+148.2%
41,854
+170.7%
0.03%
+200.0%
Q2 2023$464,848
-19.7%
15,464
-3.2%
0.01%
-31.2%
Q1 2023$578,738
-18.6%
15,974
-19.9%
0.02%
-20.0%
Q4 2022$711,188
+8.2%
19,938
+2.8%
0.02%
-9.1%
Q3 2022$657,000
+16.7%
19,398
-0.4%
0.02%
+37.5%
Q2 2022$563,000
-8.5%
19,472
+2.3%
0.02%
+33.3%
Q1 2022$615,000
-54.8%
19,028
-59.2%
0.01%
-53.8%
Q4 2021$1,360,000
+11.3%
46,635
+1.8%
0.03%
-16.1%
Q3 2021$1,222,000
+9.9%
45,822
+26.9%
0.03%
-11.4%
Q2 2021$1,112,000
+30.1%
36,105
+10.5%
0.04%
+9.4%
Q1 2021$855,000
+20.1%
32,672
+15.4%
0.03%
-3.0%
Q4 2020$712,000
+33.8%
28,310
+10.8%
0.03%
+10.0%
Q3 2020$532,000
+6.0%
25,550
+20.9%
0.03%
-63.9%
Q2 2020$502,00021,1360.08%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders